Phase I Study of Adjuvant Immunotherapy with Autologous Tumor-Infiltrating Lymphocytes in Locally Advanced Cervical Cancer

Tumor-infiltrating lymphocyte-based adoptive cell therapy following concurrent chemoradiotherapy was safe in an academic center setting, with potential effective responses in locally advanced cervical cancer patients.
[Journal of Clinical Investigation]
AbstractFull Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News